<div class="container">

<table style="width: 100%;"><tr>
<td>e1684</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Melanoma  data set</h2>

<h3>Description</h3>

<p>Eastern Cooperative Oncology Group (ECOG) data used for modeling hazard-based regression models
</p>


<h3>Format</h3>

<p>A data frame with 284 observations on the following 5 variables.
</p>

<ul>
<li>
<p> TRT: 0=control group, 1=IFN treatment group
</p>
</li>
<li>
<p> FAILTIME: observed relapse-free time
</p>
</li>
<li>
<p> FAILCENS: relapse-free censor indicator
</p>
</li>
<li>
<p> AGE:continuous variable, which is centered to the mean
</p>
</li>
<li>
<p> SEX: 0 for male, 1 fopr female
</p>
</li>
</ul>
<h3>Author(s)</h3>

<p>Abdisalam Hassan Muse, Samuel Mwalili, Oscar Ngesa, Mutua Kilai, <a href="mailto:abdisalam.hassan@amoud.edu.so">abdisalam.hassan@amoud.edu.so</a>
</p>


<h3>References</h3>

<p>Kirkwood, J. M., Manola, J., Ibrahim, J., Sondak, V., Ernstoff, M. S., &amp; Rao, U. (2004). A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma. Clinical Cancer Research, 10(5), 1670-1677.
</p>


</div>